Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3998 Target Snapshot

D(2) dopamine receptor · SINGLE PROTEIN · Bos taurus

433Compounds
178Assays
18Approved Drugs
505.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P20288. Use UniProt P20288 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P20288 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats D(2) dopamine receptor as ChEMBL target CHEMBL3998, mapped to UniProt P20288. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
D(2) dopamine receptor
SINGLE PROTEIN · Bos taurus
As of 2026-09-14
ChEMBL target ID
CHEMBL3998
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P20288
D(2) dopamine receptor
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether D(2) dopamine receptor is the right protein anchor across sources, using UniProt P20288 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelD(2) dopamine receptor
UniProt AccessionP20288
Component TypeProtein
Sequence Length444 aa

D(2) dopamine receptor

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as D(2) dopamine receptor, mapped to UniProt P20288. Sequence length is 444 aa.

Mapped IDP20288
Review nameD(2) dopamine receptor
OrganismBos taurus
Clinical Profile

Clinical Phase Distribution

18
Approved
4
Phase II
Assay Mix

Activity Type Distribution

IC50236.0
KI268.0
KD1.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL123813 10.7 Ki 0.02 Preclinical
CHEMBL317488 10.4 Ki 0.04 Preclinical
CHEMBL607228 10.18 Ki 0.066 Preclinical
CHEMBL332740 10.17 Ki 0.068 Preclinical
CHEMBL54 9.52 Ki 0.3 Approved
CHEMBL445347 9.25 Ki 0.56 Preclinical
CHEMBL1423 9.22 Ki 0.6 Approved
CHEMBL64878 9.11 IC50 0.77 Preclinical
CHEMBL54 8.92 IC50 1.2 Approved
CHEMBL301265 8.8 Kd 1.6 Approved
Distribution

pChEMBL Value Distribution

50
5.0
47
5.5
53
6.0
55
6.5
62
7.0
32
7.5
29
8.0
9
8.5
4
9.0
5
9.5
pChEMBL
Approved Drugs

Approved Drugs

ROTIGOTINE
CHEMBL1303
Approved 2006
APOMORPHINE
CHEMBL53
Approved 2001
PRAMIPEXOLE
CHEMBL301265
Approved 1997
FENOLDOPAM
CHEMBL588
Approved 1997
CLOZAPINE
CHEMBL42
Approved 1989
PERGOLIDE
CHEMBL531
Approved 1988
BUSPIRONE
CHEMBL49
Approved 1986
PIMOZIDE
CHEMBL1423
Approved 1984
METOCLOPRAMIDE
CHEMBL86
Approved 1979
DOPAMINE
CHEMBL59
Approved 1974
HALOPERIDOL
CHEMBL54
Approved 1967
CHLORPROMAZINE
CHEMBL71
Approved 1957
Assay Landscape

Assay Landscape

178
Total Assays
258
Tested Compounds
2
Assay Types
Binding — 148 assays, 258 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 83 103 6.8
assay format 35 108 6.5
cell membrane format 16 8 7.0
tissue-based format 9 15 6.4
cell-based format 5 24 6.2
Functional — 30 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 30 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine